Premium
Screening for late‐onset Pompe disease in western Denmark
Author(s) -
Hansen J. S.,
Pedersen E. G.,
Gaist D.,
Bach F. W.,
Vilholm O. J.,
Sandal B.,
Weitemeyer L.,
Nielsen K.,
Schlesinger F. E.,
Preisler N.,
Vissing J.,
Andersen H.
Publication year - 2018
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.12811
Subject(s) - medicine , disease , degenerative disease , age of onset , pediatrics , gerontology , demography , sociology
Objective Late‐onset Pompe disease ( LOPD ) is a rare autosomal recessively inherited metabolic myopathy caused by reduced activity of the lysosomal enzyme alpha‐glucosidase. In a previous screening study at two large neuromuscular university clinics in Denmark, three patients with LOPD were identified out of 103 patients screened. No systematic screening has been performed at the other neurological departments in the western part of Denmark. Thus, patients with a diagnosis of unspecified myopathy were screened for LOPD . Materials and methods At seven neurological departments in the western part of Denmark, medical records were evaluated for all patients registered with myopathy diagnosis codes ( ICD 10 codes: G 71.0‐71.9 and G 72.0‐72.9) during the period January 1, 2002, to December 31, 2012. If no specific diagnosis has been reached, patients were invited for screening. Dried blood spot ( DBS ) test was used to analyze the activity of the enzyme alpha‐glucosidase. Result A total of 654 patients were identified. From the medical records, information was obtained concerning symptoms, family history, electromyography, muscle biopsy results and creatine kinase levels. Eighty‐seven patients (13.3%) (males 61%) at a mean age of 53.3 years ( SD 16.5) fulfilled the criteria for screening. A DBS test was performed in 47 (54%) patients. In all patients, the enzyme activity was within reference values. Conclusion None of the screened patients had a reduced activity of the enzyme alpha‐glucosidase. Although the cohort studied was small, our findings do not suggest that LOPD is underdiagnosed in patients with unspecified myopathy in western Denmark.